Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia–like IBMFS ADH5/ALDH2 deficiency

31Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We have recently discovered Japanese children with a novel Fanconi anemia–like inherited bone marrow failure syndrome (IBMFS). This disorder is likely caused by the loss of a catabolic system directed toward endogenous formaldehyde due to biallelic variants in ADH5 combined with a heterozygous ALDH2*2 dominant-negative allele (rs671), which is associated with alcohol-induced Asian flushing. Phytohemagglutinin-stimulated lymphocytes from these patients displayed highly increased numbers of spontaneous sister chromatid exchanges (SCEs), reflecting homologous recombination repair of formaldehyde damage. Here, we report that, in contrast, patient-derived fibroblasts showed normal levels of SCEs, suggesting that different cell types or conditions generate various amounts of formaldehyde. To obtain insights about endogenous formaldehyde production and how defects in ADH5/ALDH2 affect human hematopoiesis, we constructed disease model cell lines, including induced pluripotent stem cells (iPSCs). We found that ADH5 is the primary defense against formaldehyde, and ALDH2 provides a backup. DNA repair capacity in the ADH5/ALDH2-deficient cell lines can be overwhelmed by exogenous low-dose formaldehyde, as indicated by higher levels of DNA damage than in FANCD2-deficient cells. Although ADH5/ALDH2-deficient cell lines were healthy and showed stable growth, disease model iPSCs displayed drastically defective cell expansion when stimulated into hematopoietic differentiation in vitro, displaying increased levels of DNA damage. The expansion defect was partially reversed by treatment with a new small molecule termed C1, which is an agonist of ALDH2, thus identifying a potential therapeutic strategy for the patients. We propose that hematopoiesis or lymphocyte blastogenesis may entail formaldehyde generation that necessitates elimination by ADH5/ALDH2 enzymes.

References Powered by Scopus

A more efficient method to generate integration-free human iPS cells

1626Citations
N/AReaders
Get full text

Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart

681Citations
N/AReaders
Get full text

The Fanconi anaemia pathway: New players and new functions

540Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Genotoxic aldehydes in the hematopoietic system

27Citations
N/AReaders
Get full text

Germline predisposition to hematopoietic malignancies

24Citations
N/AReaders
Get full text

Cell and gene therapy for anemia: Hematopoietic stem cells and gene editing

21Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Mu, A., Hira, A., Niwa, A., Osawa, M., Yoshida, K., Mori, M., … Takata, M. (2021). Analysis of disease model iPSCs derived from patients with a novel Fanconi anemia–like IBMFS ADH5/ALDH2 deficiency. Blood, 137(15), 2021–2032. https://doi.org/10.1182/blood.2020009111

Readers' Seniority

Tooltip

Researcher 6

43%

PhD / Post grad / Masters / Doc 5

36%

Professor / Associate Prof. 2

14%

Lecturer / Post doc 1

7%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 9

60%

Medicine and Dentistry 4

27%

Agricultural and Biological Sciences 1

7%

Nursing and Health Professions 1

7%

Save time finding and organizing research with Mendeley

Sign up for free